MS
Maven Securities’s ADMA Biologics ADMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-50,000
| Closed | -$330K | – | 276 |
|
2024
Q1 | $330K | Buy |
+50,000
| New | +$330K | 0.02% | 243 |
|
2023
Q2 | – | Sell |
-50,000
| Closed | -$166K | – | 250 |
|
2023
Q1 | $166K | Buy |
+50,000
| New | +$166K | ﹤0.01% | 188 |
|
2022
Q4 | – | Sell |
-15,000
| Closed | -$37K | – | 217 |
|
2022
Q3 | $37K | Sell |
15,000
-454,206
| -97% | -$1.12M | ﹤0.01% | 407 |
|
2022
Q2 | $929K | Sell |
469,206
-3,022,318
| -87% | -$5.98M | 0.03% | 123 |
|
2022
Q1 | $6.39M | Buy |
3,491,524
+175,917
| +5% | +$322K | 0.22% | 18 |
|
2021
Q4 | $4.68M | Buy |
+3,315,607
| New | +$4.67M | 0.13% | 30 |
|
2021
Q2 | – | Sell |
-750,325
| Closed | -$1.32M | – | 604 |
|
2021
Q1 | $1.32M | Buy |
+750,325
| New | +$1.32M | 0.06% | 192 |
|